Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.77
-0.15 (-2.53%)
At close: Dec 5, 2025, 4:00 PM EST
5.77
0.00 (0.00%)
After-hours: Dec 5, 2025, 6:08 PM EST
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $449.54 million as of December 5, 2025. Its market cap has increased by 120.18% in one year.
Market Cap
449.54M
Enterprise Value
235.34M
1-Year Change
120.18%
Ranking
Category
Stock Price
$5.77
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $449.54M, a decrease of -93.84%. That is a compound annual growth rate of -29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 449.54M | 181.28% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |